What We Do
The company produces a wide range of essential drugs required for use in Ghana and the entire West Africa Sub-Region and beyond. Most of our products have been registered in 18 countries mainly in West and Central Africa; these include anti-inflammatory, anti-pyretics, analgesics and, anti-infective agents especially anti-biotics and anti-malaria as well as drugs used for the treatment of common tropical diseases. The Company has registrations in major markets like Nigeria, Senegal, Côte D’Ivorie, Niger, Mali, Benin among others.
The company also undertakes contract development, production, and analysis for other companies. Phyto-Riker Pharmaceuticals, the Bermuda based entity divested majority stake in PRG in late 2005. TAPCO, a Special Purpose Vehicle initiated by the reputed financial company of Ghana, Databank Financial Services Ltd, injected the much-needed capital to revive the Company and to put it on the fast growth curve.
Currently, Overseas Private Investment Corporation (OPIC) holds 25% shares in the company whilst TransAfrica Pharmaceuticals Ltd owns majority shares of 65%, with the Government of Ghana retaining 10% interest. With the change in ownership and management the new management aims at making the company a premier, flagship pharmaceutical company in West Africa focused on addressing key disease patterns such as HIV/AIDS, Malaria and high childhood mortality diseases with high quality, cost-effective pharmaceutical products, herbal medicines, and specialized development programs.
Since December 2005 when the new management took over the focus has been on the enhancement of operational efficiency, strengthening of the company’s marketing function whilst maintaining the Company’s heritage of manufacturing high-quality products. The Company is GMP and ISO 9001-2000 certified.